In a HD cell model, pre-treatment with PRE-084 resulted in the prevention of caspase 3-cleavage, stimulation of cellular antioxidants, and a reduction in ROS in mutant huntingtin-expressing neuronal cells [152]. This evidence concerns the gene HTT and Huntington disease.